LUP Statistics
Record
- Title
- Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews
- Type
- Journal Article
- Publ. year
- 2017
- Author/s
- Mulinari, Shai; Davis, Courtney
- Department/s
- Sociology
- In LUP since
- 2017-10-09
Downloads
| Total | This Year | This Month |
| 318 | 8 | 1 |
United States of America  |
205 (65%) |
Germany  |
40 (13%) |
China  |
18 (6%) |
Sweden  |
15 (5%) |
Russian Federation  |
5 (2%) |
United Kingdom of Great Britain and Northern Ireland  |
5 (2%) |
Czechia  |
4 (1%) |
Japan  |
3 (1%) |
France  |
2 (1%) |
South Korea  |
2 (1%) |
Romania  |
2 (1%) |
Hong Kong (China)  |
2 (1%) |
Viet Nam  |
1 (0%) |
Italy  |
1 (0%) |
Cuba  |
1 (0%) |
Netherlands (Kingdom of the)  |
1 (0%) |
South Africa  |
1 (0%) |
India  |
1 (0%) |
Switzerland  |
1 (0%) |
Denmark  |
1 (0%) |
Ireland  |
1 (0%) |
Belgium  |
1 (0%) |
United Arab Emirates  |
1 (0%) |
Brazil  |
1 (0%) |
Senegal  |
1 (0%) |